The share price of Aerie Pharmaceuticals, Inc. (AERI) now
What analysts predict: $15.35
52-week High/Low: $15.37 / $4.81
50/200 Day Moving Average:
$15.19 / $10.24
This figure corresponds to the Average Price over the previous 50/200 days.
For Aerie Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Aerie Pharmaceuticals stocks, the 200-day moving average is the support level today.
Are you interested in Aerie Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Aerie Pharmaceuticals
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Aerie Pharmaceuticals share be worth in
2023 - 2027?
When should I take profit in Aerie Pharmaceuticals stock?
When should I record a loss on Aerie Pharmaceuticals stock?
What are analysts' forecasts for Aerie Pharmaceuticals stock?
What is the future of Aerie Pharmaceuticals stock?
We forecast Aerie Pharmaceuticals stock performance using neural networks based on historical data on Aerie Pharmaceuticals stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aerie Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aerie Pharmaceuticals shares. This happens once a day.
Sell or Buy Aerie Pharmaceuticals (AERI) stocks? Analytic Experts Forecasting...
February 6, 2023
We present you the most up-to-date and complete review of analytical trend forecasts and views on the AERI stock market. … Read more
Historical and forecast chart of Aerie Pharmaceuticals stock
The chart below shows the historical price of Aerie Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Aerie Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Subscribe to update forecasts!
Aerie Pharmaceuticals daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Feb 08
15.22
14.90
15.37
3.17
Feb 09
14.91
14.42
15.44
7.08
Feb 10
14.34
13.88
14.87
7.13
Feb 11
13.85
13.68
14.04
2.63
Feb 12
14.20
13.69
14.48
5.81
Feb 13
14.90
14.63
15.16
3.56
Feb 14
14.68
14.25
14.99
5.20
Feb 15
14.69
14.41
14.86
3.11
Feb 16
14.05
13.91
14.50
4.29
Feb 17
13.87
13.57
14.06
3.58
Feb 18
13.21
12.96
13.42
3.57
Feb 19
13.28
12.93
13.70
6.01
Feb 20
13.55
13.10
13.93
6.31
Feb 21
13.67
13.50
14.19
5.12
Feb 22
13.78
13.50
14.10
4.44
Feb 23
13.78
13.37
13.97
4.48
Feb 24
14.40
13.93
14.63
4.96
Feb 25
14.46
14.24
14.68
3.10
Feb 26
14.25
14.04
14.65
4.37
Feb 27
14.16
14.02
14.31
2.07
Feb 28
13.95
13.51
14.27
5.58
Mar 01
13.87
13.57
14.32
5.52
Mar 02
14.24
13.70
14.66
7.02
Mar 03
14.93
14.36
15.45
7.59
Mar 04
14.99
14.51
15.27
5.22
Mar 05
14.82
14.52
15.23
4.90
Mar 06
14.35
14.03
14.81
5.52
Mar 07
14.41
13.98
14.98
7.17
Mar 08
14.35
14.16
14.78
4.36
Mar 09
13.98
13.48
14.44
7.11
Aerie Pharmaceuticals Daily Price Targets
Aerie Pharmaceuticals Stock Forecast 02-08-2023.
Forecast target price for 02-08-2023: $15.22. Negative dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 3.069%. Pessimistic target level: 14.90 Optimistic target level: 15.37
Aerie Pharmaceuticals Stock Forecast 02-09-2023.
Forecast target price for 02-09-2023: $14.91. Negative dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 6.612%. Pessimistic target level: 14.42 Optimistic target level: 15.44
Aerie Pharmaceuticals Stock Forecast 02-10-2023.
Forecast target price for 02-10-2023: $14.34. Negative dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 6.654%. Pessimistic target level: 13.88 Optimistic target level: 14.87
Aerie Pharmaceuticals Stock Forecast 02-11-2023.
Forecast target price for 02-11-2023: $13.85. Negative dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 2.565%. Pessimistic target level: 13.68 Optimistic target level: 14.04
Aerie Pharmaceuticals Stock Forecast 02-12-2023.
Forecast target price for 02-12-2023: $14.20. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 5.490%. Pessimistic target level: 13.69 Optimistic target level: 14.48
Aerie Pharmaceuticals Stock Forecast 02-13-2023.
Forecast target price for 02-13-2023: $14.90. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 3.440%. Pessimistic target level: 14.63 Optimistic target level: 15.16
Aerie Pharmaceuticals Inc. (Nasdaq: AERI) is a publicly traded, clinical stage pharmaceutical company dedicated to discovering, developing and commercializing first-class treatments for patients with glaucoma and other eye conditions.
Aerie Pharmaceuticals Address
4301 EMPEROR BOULEVARD, SUITE 400, DURHAM, NC, US
Market Capitalization:
753 615 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA:
-6 545 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
N/A
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-1.472
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
0.233
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
4.292
Enterprise Value (EV) /Revenue
EV To EBITDA:
-350.17
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
49417400
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website